Loading...

MetaVia Inc.

MTVA•NASDAQ
Healthcare
Biotechnology
$1.88
$0.77(69.37%)
U.S. Market opens in 9h 33m

MetaVia Inc. (MTVA) Stock Overview

Explore MetaVia Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap4.1M
P/E Ratio-0.68
EPS (TTM)$-4.25
ROE-1.73%
Fundamental Analysis

AI Price Forecasts

1 Month$1.11
3 Months$2.33
1 Year Target$8.00

MTVA Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of MetaVia Inc. (MTVA) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 67.66, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $8.00.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -0.68 and a market capitalization of 4.1M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
69.37%
5-Day Change
54.10%
1-Month Change
34.29%
3-Month Change
20.51%
6-Month Change
-77.62%
Year-to-Date (YTD) Change
-77.67%
1-Year Change
-75.55%
3-Year Change
-93.24%
5-Year Change
-93.24%
All-Time (Max) Change
-93.24%

Contact Information

https://www.metaviatx.com
857 702 9600
545 Concord Avenue, Cambridge, MA, 02138

Company Facts

9 Employees
IPO DateAug 5, 2016
CountryUS
Actively Trading

Frequently Asked Questions